ArticleMarine biotechnology (New York, N.Y.)2026
GC-MS Profiling, Cytotoxicity and Antiviral Activity of Caulerpa lentillifera and C. macrodisca from Northern Coastal Waters of Borneo Island, Eastern Malaysia.
Article in Marine biotechnology (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioactive compounds derived from marine sources have gained global attention in aquaculture disease control due to their novelty and promising medicinal value. However, marine algae as an alternative source remain underexplored particularly along the Borneo coast. In this study, marine algae specifically Caulerpa lentillifera and C. macrodisca were investigated on their toxicity and antiviral activity as well as bioactive profiling. The cytotoxicity was evaluated using five fish cell lines. The antiviral activity was assessed against infectious hematopoietic necrosis virus (IHNV). Results showed that both Caulerpa species exhibited moderate cytotoxicity on E-11 and EPC cells after six and 14 days, respectively. The antiviral assay revealed higher viral titer reduction by C. macrodisca (1.80 log₁₀ TCID₅₀ mL⁻¹; 98.38%) compared to C. lentillifera (0.46 log₁₀ TCID₅₀ mL⁻¹; 65.19%) after 10 days. GC-MS identified multiple potential bioactive metabolites, including two potential antiviral compounds from C. lentillifera and five potential antiviral compounds from C. macrodisca. These findings highlight the potential of Bornean Caulerpa species as a novel source of marine-derived antiviral metabolites for sustainable fish health management in aquaculture.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.